Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02253225 · ClinicalTrials.gov registry record

Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study

A clinical trial of Bipolar Disorder and Major Depression, sponsored by Massachusetts General Hospital.

Completed
Registry status
32
Enrollment target
1
Study location

NCT02253225: Completed study of Bipolar Disorder and Major Depression, sponsored by Massachusetts General Hospital.

NCT02253225 is a study of Bipolar Disorder and Major Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 32 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02253225, a study of Bipolar Disorder and Major Depression, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.

Primary Outcome

Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of self processing and self focus.

Interventions

  • OTHER Functional Magnetic Resonance Imaging (fMRI)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2013-01
Est. Completion 2020-01
Massachusetts General Hospital

2,032 total trials

What the finished NCT02253225 record still lists

NCT02253225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower).

The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Functional Magnetic Resonance Imaging (fMRI) is the first listed.

NCT02253225 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02253225 about?

NCT02253225 is a clinical study titled "Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study". The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.

What is the current status of trial NCT02253225?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-01. Estimated completion is 2020-01.

What conditions does trial NCT02253225 study?

This clinical trial studies the following conditions: Bipolar Disorder, Major Depression, Rumination.

What interventions are being tested in trial NCT02253225?

The interventions under investigation include: Functional Magnetic Resonance Imaging (fMRI) (OTHER).

Who is sponsoring clinical trial NCT02253225?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02253225 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02253225's enrollment target sits among peer trials

32 134th of 162 higher than 28 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02253225, the US trial registry maintained by the National Library of Medicine. NCT02253225 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.